The critically important role of alveolar macrophages in the defence of the host against inhaled particles, including microorganisms and environmental toxins, has been well established.' Yet the function of alveolar macrophages in protecting against tumour growth is still poorly understood. Several reports recently reviewed by Kaltreider2 give evidence for a role of alveolar macrophages within immunologically mediated host defence mechanisms, leading to either activation or suppression of mitogen induced lymphocyte proliferation, depending on the experimental conditions. It is well established also that macrophages or monocytes from sources other than the lung play an important part in antitumour immunity,34 their chemotaxis being frequently impaired in patients with various types of neoplasia.5-9 Chemotaxis along an attractant gradient is an important function of macrophages which allows them to reach the site of arl infection or tumour.
macrophages from patients with other lung diseases and from healthy volunteers. We report here an intrinsic chemotactic defect in alveolar macrophages from patients with primary lung cancer and sarcoidosis, which was not found in cells sampled from patients with the other conditions we tested. (mean 59) with primary bronchogenic carcinoma. Forty three were smokers and five were non-smokers. Thirty individuals had intrathoracic disease only. Eighteen patients had distant metastases. The histological types were: 28 squamous cell carcinomas, six small cell cancers, six adenocarcinomas, and eight undifferentiated tumours. Fourteen of the 48 patients had a concomitant infection or severe local inflammation. According to the diagnostic criteria for inflammation and infection, there had to be an inflamed bronchial mucosa at bronchoscopy associated with either leucocytosis (polymorphonuclear leucocytes over 10-0 x 109/l), fever higher than 38°C, or other systemic features of inflammation (fibrinaemia >4.5 g/l). Group 6 comprised 14 patients: nine men and five women aged 35-70 years (mean 55) with pulmonary metastases from primary tumours originating in the breast (5), head and neck (4), testis (1), or colon (1); in three the site of the primary tumour was unknown. Six were smokers and eight non-smokers.
Methods

ALVEOLAR LAVAGE
Segmental lavage through a fibreoptic bronchoscope was performed under local anaesthesia as previously described.' '°In brief, healthy volunteers of group 1 and control patients of groups 2, 3, and 4 underwent lavage in the lingular territory. In the patients with primary bronchogenic carcinoma (group 5) alveolar lavage was performed before specific treatment at the tumour site in 23 patients. A bordering territory was lavaged in the other 25 patients because bronchial obstruction by the tumour had rendered injection and aspiration difficult at the site of the tumour. In 14 cases of squamous cell carcinoma lavage was also performed in the lung opposite to the tumour site. In patients of group 6 with pulmonary metastases lavage was carried out in territories where there was radiographic evidence of tumour.
ALVEOLAR MACROPHAGE CHEMOTAXIS
Cells were recovered by centrifugation and then washed and resuspended in phosphate buffered saline (PBS). Total and differential cell counts of an aliquot were performed on a cytocentrifuge preparation after Wright Giemsa staining. Cells were again centrifuged for 10 minutes at 500 g, and finally resuspended at a concentration of 1-5 x 106 viable cells (trypan blue test) per ml of RPMI-1640 medium. Random migration and chemotaxis were measured in modified Boyden chambers with 8-0 ,um pore millipore filters."'2 The 129 samples were tested in the presence of autologous zymosan activated serum (1 mg zymosan/ml serum, one hour at 37°C, then heated at 56°C for 30 minutes and diluted 1:20 in sterile PBS) as chemoattractant. Concomitantly, alveolar macrophages from six lung cancers were tested also against human AB zymosan activated serum, and samples from five lung cancers in the presence of 3 x 10-8 mmol/l of formylmethonine-leucyl-phenylalanine (F-Met-Leu-Phe) per ml. The number of macrophages migrating across the entire thickness of the filter after 90 minutes of incubation was determined after staining with haematoxylin. All the responding cells were in one optical plane on the lower surface of the filter, and the total number could be readily determined. The results are expressed as the mean cell count (with standard deviation in parentheses) in 10 microscopic fields (x 100) in duplicate assays. In 14 patients with sarcoidosis purified, lymphocyte free alveolar macrophages were obtained by allowing them to adhere to glass for 60 minutes, and the data were compared with those obtained with the total, unfractionated cell population.
STATISTICAL ANALYSIS
Differences between groups were compared by variance analysis (F test). Means were compared with Student's t test.
Results
The volume of recovered fluid, total cell yield, percentage of each cell type, and viability were not significantly different between the various groups (including healthy smokers and non-smokers) with the exception of patients with sarcoidosis, where the percentage of lymphocytes was higher than in the other groups (table 1) .
The results shown in table 2 indicate that random migration performed as a control test in the presence of autologous serum diluted 1:20 in PBS was no different for patients with bronchial carcinoma or metastases from the result observed for healthy controls. Alveolar macrophages from patients with longstanding or recent bronchopulmonary infections, however, showed random migration significantly (p < 0.02) above that of healthy controls.
Neither sex nor smoking habits showed any influence on alveolar macrophage chemotaxis in the healthy volunteer group. Chemotaxis was affected (24) 33 (28) 63 (21) 34 (20) (20) 28 (20) 88 (10) 6 (5) 3 (2) 75 (12) 6: Patients with pulmonary metastasis (n = 14) 74 (23) 20 (12) 91 (6) 7 (5) 2 (2) 71 (13) by clinical state (table 2) ; it was significantly less (p <0-01) in patients with bronchogenic carcinoma than in controls, and there were no differences in values between cells recovered at the tumour site (mean 4 9 (SD 2.7)) and those from the homolateral lung in a territory close to the tumour (5.4 (3.6)).
The dysfunction of alveolar macrophages from patients with primary bronchial carcinoma was independent of the histological type-squamous cell carcinoma yielded 4 (table 3) . In contrast (table 2) , the chemotaxis values of alveolar macrophages from patients with lung metastases of tumours from other sources (group 6) were similar to those of healthy controls (group 1). Defective alveolar macrophage chemotaxis was not, however, specific for primary bronchial carcinoma; the results for patients with endothoracic sarcoidosis (group 4) were similar to those for patients with bronchial carcinoma, showing chemotaxis significantly below (p < 0.01) that found in healthy controls. Table 2 also shows that depletion of lymphocytes before the test did not affect the data for sarcoidosis.
Chemotaxis was significantly more inhibited in alveolar macrophages from the tumour territory (p < 0.01) than in macrophages from the contra- 21 and a low molecular weight inhibitory factor has been isolated from growing neoplasia.22 A low molecular weight suppressor factor with prostaglandin like activity has, however, also been isolated from alveolar macrophages.2324 Nearby lymphocytes might also be affected by reduced alveolar macrophage chemotaxis. It seems probable that suppressive factors are locally produced as chemotaxis was more inhibited in samples from the tumour territory than
